OK
The material selection platform
Plastics & Elastomers
The material selection platform
Plastics & Elastomers
Product News

Mitsubishi Unveils Regulatory-compliant POM Resins for Medical Devices

Published on 2021-06-08. Author : SpecialChem

TAGS:  Medical   

MEP-medical-standard-POM Mitsubishi Engineering-Plastics Corporation (MEP) has developed a new polyacetal resin (POM) series, the Iupital MA Series, that is compliant with medical standards. The MA series is available in a range of standard, high-flow, high-rigidity, and low-friction grades, enabling greater design flexibility for medical devices and equipment, which are becoming smaller and lighter.

Low-friction Grade for Improved Comfort


In particular, the low-friction grade MAL20 has greatly improved sliding performance with POM. In the past, combining POM parts would generate squeaking noise and friction, so designs would combine different materials in order to avoid these issues.

MAL20 suppresses friction and wear, even when combined with ordinary POM, achieving quiet, smooth movement, which greatly improves comfort when used in medical devices.

The Iupital MA series meets the quality and regulatory requirements for medical materials and is suitable for applications such as drug inhalers for COPD and asthma, injection devices such as insulin pens, and parts for medical devices.

MEP vice president, Katsushige Hayashi, said, "These new materials, which exhibit a variety of excellent properties, will expand the range of designs, especially for medical devices and instruments, and contribute to improving their functionality. In particular, the sliding grade MAL20 eliminates the discomfort caused by noise and friction due to contact between POMs, providing users with comfort and ease of use."

In addition, with the MA series, MEP will offer a coloring masterbatch for color mixing. MEP supports part design not only in terms of physical characteristics, but also in terms of visual design.


Source: Mitsubishi Engineering-Plastics Corporation
DSM
Channel Alerts

Receive weekly digests on hot topics

Back to Top